Clinical Trial Results: Positive data boosts confidence, driving demand and price up. Conversely, negative or inconclusive results can trigger a sell-off.

Regulatory Approvals: FDA approval for drugs significantly increases valuation. Delays or rejections negatively impact the stock.

Market Sentiment: General investor optimism or pessimism influences all stocks, including ATHA.US.

Competition: Development of competing therapies can dilute market share expectations, lowering ATHA.US price.

Partnerships and Licensing: Deals with larger pharmaceutical companies often bring funding and validation, increasing stock value.

Financial Performance: Company's cash position and burn rate are crucial. Strong financials provide stability and investor confidence.

Patent Protection: Strong patent portfolio protects future revenues, making ATHA.US more attractive.

Economic Conditions: Economic downturns can reduce investment in biotech, impacting ATHA.US stock.

Company News: Announcements about new research, management changes, or strategic initiatives affect price.

Analyst Ratings: Upgrades from analysts typically lead to price increases, while downgrades can cause declines.